Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-04-097047
Filing Date
2004-06-01
Accepted
2004-06-01 17:16:58
Documents
11
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT #2 TO FORM 10-K d10ka.htm 10-K/A 906701
2 CONSENT OF ERNST & YOUNG LLP dex231.htm EX-23.1 1683
3 CEO CERTIFICATION PURSUANT TO SECTION 302 dex311.htm EX-31.1 6898
4 CFO CERTIFICATION PURSUANT TO SECTION 302 dex312.htm EX-31.2 6892
5 CEO & CFO CERTIFICATION PURSUANT TO SECTION 906 dex321.htm EX-32.1 6079
6 GRAPHIC g17577g19z10.jpg GRAPHIC 88980
7 GRAPHIC g17577g25e10.jpg GRAPHIC 70946
8 GRAPHIC g17577g40b41.jpg GRAPHIC 66230
9 GRAPHIC g17577g49q72.jpg GRAPHIC 82270
10 GRAPHIC g17577g63c11.jpg GRAPHIC 91290
11 GRAPHIC g17577g71o60.jpg GRAPHIC 65610
  Complete submission text file 0001193125-04-097047.txt   1396451
Mailing Address 125 SUMMER STREET BOSTON MA 02110
Business Address 125 SUMMER STREET BOSTON MA 02110 6179332130
POINT THERAPEUTICS INC (Filer) CIK: 0000919745 (see all company filings)

EIN.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-23776 | Film No.: 04842145
SIC: 2834 Pharmaceutical Preparations